Oura postpones $15 billion IPO amid market uncertainty
Smart ring maker delays stock market debut citing challenging IPO conditions
1IPO plans abruptly withdrawn
Oura has scrapped its planned Nasdaq listing just days after announcing a $15 billion valuation target. The Finnish smart ring maker filed documents last week to raise $2.2 billion but cited unfavorable IPO market conditions for the postponement. This follows similar delays by companies like Holtec International, signaling broader market challenges. Oura CEO Tom Hale emphasized having the flexibility to choose their timing for going public.
2Challenging IPO landscape
The current IPO market faces multiple headwinds including rising energy costs, military conflicts, and inflation concerns driving central bank rate hikes. Samuel Kerr of Mergermarket notes a dramatic shift from expectations just weeks ago. The 10-year US Treasury yield recently hit 2007 levels, reflecting investor caution. These macroeconomic factors are causing companies to reassess public listing timelines.
3Oura's financial performance
In its last full fiscal year ending September 2025, Oura reported $907.8 million in sales with $23.5 million pre-tax profit, up from $6.2 million the previous year. For the first nine months of 2025, sales reached $1.2 billion with $70 million pre-tax income. The company planned to offer shares at $40-$44, targeting the premium wearable tech market with its $300+ smart rings.
4Product controversy persists
Oura faces a class action lawsuit alleging false advertising about sleep tracking accuracy. Clarkson Law Firm argues sleep occurs in the brain, not fingers. Oura maintains its technology uses multiple physiological signals to estimate sleep stages. The company states the IPO delay is unrelated to the lawsuit, standing by its scientific claims.
5Wearable tech market position
Founded in 2013, Oura has become a leader in health-tracking wearables with its San Francisco-based global operations. The rings monitor heart rate, sleep patterns and other biometrics through companion app analysis. While competing with fitness trackers, Oura positions itself as a premium health monitoring tool rather than general activity tracker.
6Strategic timing considerations
CEO Hale framed the IPO as just one milestone, suggesting the company can afford to wait for optimal conditions. This contrasts with startups needing immediate capital. Oura's strong financials provide flexibility amid market volatility. The delay allows monitoring of how other tech IPOs perform in coming months before committing.
7Investor confidence erosion
The postponement reflects growing skepticism about new listings as rising rates make future cash flows less attractive. With the Fed continuing tightening, tech valuations face downward pressure. Oura's $15 billion target would have significantly exceeded its current revenue multiples, requiring perfect market conditions.
8Broader industry implications
Oura's decision signals caution for other tech companies considering IPOs in 2025. The wearable tech sector must now navigate both market skepticism and regulatory scrutiny over health claims. Successful future listings may require clearer paths to profitability and more conservative valuations than during the zero-rate era.
Original article: BBC News — Oura postpones $15 billion IPO amid market uncertainty